StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.70−0.17 (-8.85%)

Close on Nov 18, 2026Market cap $30.81MP/E –Yield –

Alterity Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was -A$22.52M. The highest annual figure on record is -A$5.87M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$22.52M–
FY2025Jun 30, 2025-A$11.45M–
FY2024Jun 30, 2024-A$12.61M–
FY2023Jun 30, 2023-A$20.04M–
FY2022Jun 30, 2022-A$12.34M–
FY2021Jun 30, 2021-A$17.33M–
FY2020Jun 30, 2020-A$9.43M–
FY2019Jun 30, 2019-A$13.95M–
FY2018Jun 30, 2018-A$6.25M–
FY2017Jun 30, 2017-A$5.87M–
FY2016Jun 30, 2016-A$7.42M–

More Alterity Therapeutics figures

See a number that looks wrong?